glp-1 agonist and heart failure The effect of receptor agonists on cardiac remodeling in patients with preserved reduced ejection fraction: a systematic review and meta-analysis | Heart Failure Reviews GLP-1 Agonists in Cardiovascular Diseases:

These EECs are classified based on the hormones they produce, such as serotonin-producing enterochromaffin cells (ECs), cholecystokini (CCK)-producing I-cells, GIP-producing K-cells, GLP-1 producing L-cells, somatostatin (SST)-producing D-cells, neurotensin (NTS)-producing N-cells, secretin (SCT)-producing S-cells and ghrelin (GHRL)-producing X cells

But for many sufferers, the problem stems from an underlying vitamin B12 deficiency

It helps in the transfer of fatty acid groups into the mitochondrial membrane, which is essential for cellular energy production.

The most prominent one is the ability to deliver more power which translates into a higher Rate of Fire (ROF)